Company / Shares Outstanding
4D Molecular Therapeutics, Inc. Shares Outstanding History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
45.8M
FY2025
5-year range
26.7M / 45.8M
FY2021-FY2025
Trend
+6.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 5 consecutive years, from 5178955.00 in FY2020 to 45793942.00 in FY2025.
Based on SEC 10-K filings.
45793942.00 in FY2025 with a 5-year CAGR of +54.6%.
Increased from 32626627.00 to 45793942.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +12.4%
- 5-Year CAGR
- +54.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 4D Molecular Therapeutics, Inc.'s shares outstanding has grown for 5 consecutive years.
- In FY2025, shares outstanding increased 6.3% year-over-year.
- Lowest shares outstanding in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 45.8M | +6.3% |
| FY2024 | 43.1M | +32.0% |
| FY2023 | 32.6M | +1.2% |
| FY2022 | 32.2M | +20.8% |
| FY2021 | 26.7M | +415.2% |
| FY2020 | 5.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026